DEXLANSOPRAZOLE

DEXLANSOPRAZOLE was reported 41740 times

DEXLANSOPRAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RENAL HAEMANGIOMA 786 0.9862
1 ANTACID THERAPY 93 0.7154
2 SLEEP DISORDER THERAPY 129 0.6515
3 ANALGESIC THERAPY 138 0.4299
4 APPENDICOLITH 164 0.4238
5 SYNOVIAL FLUID ANALYSIS 36 0.4138
6 RED BLOOD CELL SEDIMENTATION RATE 115 0.4122
7 REBOUND ACID HYPERSECRETION 1167 0.3854
8 DRUG THERAPY 127 0.3746
9 ANTICOAGULANT THERAPY 94 0.3310
10 CONGENITAL HIATUS HERNIA 68 0.2982
11 MALIGNANT MELANOMA STAGE 0 59 0.2823
12 END STAGE RENAL DISEASE 4888 0.2677
13 CHRONIC KIDNEY DISEASE 16103 0.2117
14 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 171 0.1845
15 NEPHROGENIC ANAEMIA 840 0.1812
16 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 180 0.1695
17 HYPERPARATHYROIDISM SECONDARY 392 0.1563
18 GRANULOMA SKIN 128 0.1559
19 RENAL INJURY 4339 0.1459
20 SERUM AMYLOID A PROTEIN INCREASED 22 0.1419
21 BACTEROIDES INFECTION 37 0.1418
22 CERVIX NEOPLASM 19 0.1387
23 HYPERCHLORHYDRIA 755 0.1282
24 ENTHESOPATHY 200 0.1278
25 ARTERIOVENOUS FISTULA OCCLUSION 22 0.1257
26 BONE HYPERTROPHY 19 0.1180
27 TUBULOINTERSTITIAL NEPHRITIS 2191 0.1168
28 TOTAL LUNG CAPACITY INCREASED 27 0.0993
29 BLOOD PARATHYROID HORMONE DECREASED 147 0.0991
30 TOTAL LUNG CAPACITY DECREASED 147 0.0920
31 TENOSYNOVITIS 246 0.0891
32 TENOSYNOVITIS STENOSANS 46 0.0826
33 HYPERPHOSPHATAEMIA 175 0.0813
34 RENAL HYPERTENSION 23 0.0737
35 ALANINE AMINOTRANSFERASE ABNORMAL 149 0.0706
36 RHEUMATOID NODULE 186 0.0675
37 DRUG SPECIFIC ANTIBODY 90 0.0657
38 LUNG OPACITY 171 0.0648
39 HYPERTENSIVE NEPHROPATHY 68 0.0637
40 PANNICULITIS 149 0.0615
41 PLEURITIC PAIN 166 0.0601
42 SYNOVIAL DISORDER 26 0.0571
43 BLOOD PHOSPHORUS INCREASED 156 0.0571
44 BLUE TOE SYNDROME 21 0.0536
45 PEAK EXPIRATORY FLOW RATE DECREASED 23 0.0523
46 ACUTE KIDNEY INJURY 7811 0.0510
47 REBOUND EFFECT 576 0.0509
48 RENAL FAILURE 6722 0.0506
49 RHEUMATOID LUNG 48 0.0503
50 BLOOD PRESSURE DIASTOLIC ABNORMAL 105 0.0412
51 ALLERGY TO CHEMICALS 49 0.0393
52 PNEUMOCOCCAL INFECTION 23 0.0389
53 C-REACTIVE PROTEIN ABNORMAL 224 0.0349
54 BLOOD ALKALINE PHOSPHATASE ABNORMAL 30 0.0333
55 DEFAECATION DISORDER 22 0.0328
56 IRON DEFICIENCY 147 0.0327
57 CENTRAL OBESITY 23 0.0311
58 BLOOD PRESSURE SYSTOLIC ABNORMAL 76 0.0307
59 AORTIC STENOSIS 106 0.0304
60 NEPHROPATHY 269 0.0288
61 SKIN NECROSIS 149 0.0287
62 SPUTUM DISCOLOURED 272 0.0286
63 BLOOD URIC ACID INCREASED 161 0.0279
64 TONGUE DISORDER 200 0.0276
65 BRONCHIECTASIS 181 0.0268
66 ESSENTIAL HYPERTENSION 49 0.0267
67 DRUG TOLERANCE DECREASED 75 0.0267
68 TERMINAL INSOMNIA 47 0.0265
69 SCLERITIS 42 0.0262
70 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 131 0.0258
71 ENDOMETRIOSIS 118 0.0247
72 KLEBSIELLA BACTERAEMIA 23 0.0242
73 BLOOD CALCIUM INCREASED 210 0.0239
74 HYPOPHOSPHATAEMIA 175 0.0237
75 DIABETIC NEPHROPATHY 51 0.0232
76 ULCER 361 0.0227
77 MYASTHENIA GRAVIS 180 0.0223
78 RALES 129 0.0222
79 CREPITATIONS 66 0.0221
80 RESPIRATORY SYMPTOM 57 0.0200
81 RENAL ATROPHY 25 0.0200
82 THERAPEUTIC REACTION TIME DECREASED 58 0.0199
83 NEPHROSCLEROSIS 22 0.0198
84 APPENDICITIS 179 0.0191
85 RESTRICTIVE PULMONARY DISEASE 22 0.0188
86 BLOOD PRESSURE SYSTOLIC INCREASED 362 0.0185
87 GRANULOMA 63 0.0182
88 GASTROOESOPHAGEAL REFLUX DISEASE 1465 0.0182
89 ANTINUCLEAR ANTIBODY POSITIVE 59 0.0181
90 BLOOD PRESSURE DIASTOLIC DECREASED 132 0.0179
91 BLOOD TEST ABNORMAL 249 0.0177
92 RENAL MASS 36 0.0175
93 ASPIRATION 191 0.0174
94 FORCED EXPIRATORY VOLUME DECREASED 49 0.0173
95 ECHOCARDIOGRAM ABNORMAL 24 0.0171
96 OBSTRUCTIVE AIRWAYS DISORDER 188 0.0169
97 BLOOD PRESSURE DIASTOLIC INCREASED 77 0.0167
98 GASTRIC POLYPS 37 0.0164
99 SYNOVITIS 293 0.0162
100 CALCIUM DEFICIENCY 20 0.0154
101 VENTRICULAR FIBRILLATION 171 0.0154
102 CUSHINGOID 49 0.0153
103 BLOOD PRESSURE SYSTOLIC DECREASED 69 0.0152
104 TENDONITIS 234 0.0151
105 BENIGN PROSTATIC HYPERPLASIA 78 0.0151
106 DRUG TOLERANCE 76 0.0150
107 BREATH SOUNDS ABNORMAL 72 0.0146
108 FAECES SOFT 105 0.0144
109 BODY TEMPERATURE DECREASED 142 0.0144
110 FEAR OF INJECTION 102 0.0143
111 TROPONIN INCREASED 103 0.0135
112 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 230 0.0134
113 HYPERCALCAEMIA 161 0.0130
114 BRONCHIAL DISORDER 20 0.0129
115 FULL BLOOD COUNT ABNORMAL 135 0.0128
116 HYPERLIPIDAEMIA 147 0.0123
117 INJECTION SITE OEDEMA 21 0.0122
118 RED BLOOD CELL SEDIMENTATION RATE INCREASED 134 0.0121
119 CARDIOGENIC SHOCK 172 0.0120
120 SYNOVIAL CYST 55 0.0119
121 RENAL CYST 94 0.0118
122 BACTERIAL INFECTION 217 0.0116
123 SINUS PAIN 27 0.0116
124 PULMONARY FIBROSIS 220 0.0115
125 BASAL CELL CARCINOMA 176 0.0113
126 INCORRECT PRODUCT ADMINISTRATION DURATION 241 0.0111
127 MICTURITION URGENCY 122 0.0107
128 JOINT INJURY 224 0.0105
129 RENAL NEOPLASM 22 0.0104
130 BLOOD IMMUNOGLOBULIN E INCREASED 25 0.0103
131 REGURGITATION 35 0.0102
132 GOUT 182 0.0101
133 PULMONARY MASS 151 0.0101
134 INFUSION SITE BRUISING 21 0.0097
135 SKIN ULCER 251 0.0097
136 BLOOD PRESSURE FLUCTUATION 227 0.0094
137 NEURALGIA 229 0.0094
138 ATELECTASIS 89 0.0092
139 RENAL TUBULAR NECROSIS 90 0.0092
140 JOINT EFFUSION 63 0.0091
141 POOR VENOUS ACCESS 93 0.0090
142 HIATUS HERNIA 116 0.0089
143 DRUG ERUPTION 158 0.0089
144 RENAL COLIC 20 0.0088
145 SCLERODERMA 32 0.0088
146 PSORIATIC ARTHROPATHY 356 0.0088
147 MUCOUS STOOLS 43 0.0087
148 DYSPNOEA AT REST 25 0.0086
149 RENAL IMPAIRMENT 725 0.0086
150 DEFAECATION URGENCY 60 0.0086
151 INFUSION SITE HAEMORRHAGE 28 0.0085
152 HYPERCHOLESTEROLAEMIA 82 0.0085
153 URINARY HESITATION 20 0.0084
154 LIVER FUNCTION TEST INCREASED 179 0.0083
155 UPPER RESPIRATORY TRACT INFECTION 381 0.0082
156 INFUSION SITE PRURITUS 26 0.0082
157 ANAL FISSURE 44 0.0082
158 OESOPHAGEAL DISORDER 31 0.0080
159 BURSITIS 96 0.0079
160 TRANSAMINASES INCREASED 175 0.0079
161 POLYP 51 0.0078
162 PULMONARY FUNCTION TEST DECREASED 34 0.0078
163 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 373 0.0078
164 SCOLIOSIS 48 0.0077
165 PRE-EXISTING CONDITION IMPROVED 47 0.0075
166 LOWER RESPIRATORY TRACT INFECTION 341 0.0075
167 VAGINAL INFECTION 35 0.0074
168 IMPAIRED GASTRIC EMPTYING 101 0.0074
169 ABDOMINAL RIGIDITY 20 0.0074
170 FAECAL CALPROTECTIN INCREASED 23 0.0073
171 CLOSTRIDIUM DIFFICILE INFECTION 155 0.0071
172 MUSCULOSKELETAL STIFFNESS 621 0.0071
173 OESOPHAGEAL PAIN 28 0.0071
174 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 365 0.0070
175 ASTHMA 787 0.0070
176 DRUG INTOLERANCE 669 0.0069
177 C-REACTIVE PROTEIN INCREASED 251 0.0069
178 KIDNEY INFECTION 134 0.0068
179 FLANK PAIN 64 0.0068
180 BLOOD IRON DECREASED 81 0.0068
181 FACET JOINT SYNDROME 22 0.0068
182 HAEMOPTYSIS 187 0.0067
183 MULTIPLE ORGAN DYSFUNCTION SYNDROME 189 0.0067
184 HEART RATE DECREASED 234 0.0067
185 ARTHRITIS 522 0.0066
186 DRUG SPECIFIC ANTIBODY PRESENT 43 0.0066
187 WHEEZING 391 0.0066
188 INFLAMMATION 334 0.0065
189 TENDERNESS 67 0.0064
190 EPIGASTRIC DISCOMFORT 25 0.0064
191 HAEMOGLOBIN INCREASED 29 0.0064
192 NOCTURIA 77 0.0063
193 ASCITES 186 0.0063
194 VULVOVAGINAL DRYNESS 20 0.0062
195 VITAMIN B12 DEFICIENCY 25 0.0062
196 GASTROINTESTINAL MOTILITY DISORDER 33 0.0062
197 SECRETION DISCHARGE 77 0.0061
198 CONTRAINDICATED PRODUCT ADMINISTERED 186 0.0061
199 RENAL PAIN 65 0.0061
200 CLOSTRIDIUM DIFFICILE COLITIS 65 0.0061
201 ENTERITIS 39 0.0061
202 SENSITIVITY TO WEATHER CHANGE 32 0.0061
203 PULMONARY TOXICITY 43 0.0061
204 PEPTIC ULCER 20 0.0060
205 CONJUNCTIVAL HAEMORRHAGE 23 0.0060
206 OESOPHAGEAL ULCER 23 0.0060
207 URINE ODOUR ABNORMAL 35 0.0059
208 SEASONAL ALLERGY 84 0.0059
209 CARPAL TUNNEL SYNDROME 83 0.0059
210 MACULOPATHY 21 0.0059
211 HEART RATE ABNORMAL 33 0.0059
212 DYSPEPSIA 581 0.0059
213 BLOOD CREATININE INCREASED 384 0.0059
214 DIALYSIS 83 0.0058
215 FRUSTRATION TOLERANCE DECREASED 47 0.0058
216 MUSCLE STRAIN 50 0.0058
217 NODULE 75 0.0057
218 ABNORMAL FAECES 47 0.0057
219 ASPARTATE AMINOTRANSFERASE INCREASED 304 0.0057
220 INFUSION SITE SWELLING 36 0.0057
221 URINE ABNORMALITY 26 0.0057
222 BLOOD MAGNESIUM DECREASED 49 0.0057
223 ANAL INCONTINENCE 51 0.0057
224 INFUSION SITE PAIN 73 0.0057
225 ANORECTAL DISCOMFORT 30 0.0056
226 PHARYNGITIS STREPTOCOCCAL 61 0.0056
227 PRODUCTIVE COUGH 269 0.0056
228 HEART RATE IRREGULAR 127 0.0056
229 BRONCHITIS 413 0.0056
230 ANAL ABSCESS 30 0.0056
231 SINUS CONGESTION 75 0.0055
232 WEIGHT FLUCTUATION 58 0.0055
233 BLADDER DISORDER 55 0.0055
234 APHONIA 77 0.0055
235 LARGE INTESTINE POLYP 38 0.0055
236 FIBROMYALGIA 133 0.0055
237 INFUSION RELATED REACTION 362 0.0055
238 INCREASED UPPER AIRWAY SECRETION 28 0.0054
239 TRIGGER FINGER 22 0.0054
240 OSTEOMYELITIS 97 0.0054
241 ABDOMINAL DISTENSION 557 0.0053
242 PHARYNGITIS 66 0.0053
243 DRY MOUTH 431 0.0053
244 ABDOMINAL HERNIA 24 0.0053
245 VIRAL UPPER RESPIRATORY TRACT INFECTION 25 0.0053
246 FREQUENT BOWEL MOVEMENTS 142 0.0053
247 EAR DISORDER 24 0.0052
248 VITAMIN D DEFICIENCY 51 0.0052
249 RHINORRHOEA 338 0.0052
250 RESPIRATION ABNORMAL 36 0.0052
251 POST-TRAUMATIC STRESS DISORDER 35 0.0052
252 STREPTOCOCCAL INFECTION 29 0.0052
253 DIVERTICULUM 37 0.0052
254 RASH PRURITIC 282 0.0052
255 BLOOD CHOLESTEROL INCREASED 240 0.0051
256 EAR PAIN 100 0.0051
257 INFUSION SITE EXTRAVASATION 32 0.0051
258 DEFORMITY 48 0.0051
259 NEPHROLITHIASIS 235 0.0051
260 ORAL HERPES 100 0.0051
261 INFUSION SITE ERYTHEMA 43 0.0051
262 GASTRIC DISORDER 175 0.0051
263 TOOTH INFECTION 67 0.0051
264 EAR INFECTION 135 0.0051
265 THERAPEUTIC PRODUCT EFFECT DECREASED 227 0.0051
266 ABDOMINAL PAIN 1178 0.0051
267 PULMONARY THROMBOSIS 55 0.0050
268 MENISCUS INJURY 31 0.0050
269 DIVERTICULUM INTESTINAL 22 0.0050
270 DYSPNOEA EXERTIONAL 189 0.0050
271 SPINAL OSTEOARTHRITIS 44 0.0050
272 MUSCULOSKELETAL DISORDER 95 0.0050
273 HYPERAESTHESIA 41 0.0050
274 NECK PAIN 278 0.0050
275 FOOT FRACTURE 94 0.0050
276 GASTRITIS 130 0.0049
277 LUNG DISORDER 242 0.0049
278 POSTOPERATIVE WOUND INFECTION 33 0.0049
279 GENERAL PHYSICAL HEALTH DETERIORATION 562 0.0049
280 HYPERVOLAEMIA 24 0.0049
281 CORONARY ARTERY DISEASE 147 0.0048
282 OESOPHAGITIS 53 0.0048
283 SPINAL STENOSIS 20 0.0048
284 DIVERTICULITIS 134 0.0048
285 FEEDING DISORDER 98 0.0048
286 SINUSITIS 493 0.0048
287 OROPHARYNGEAL PAIN 445 0.0048
288 IRRITABLE BOWEL SYNDROME 103 0.0048
289 GASTROINTESTINAL INFECTION 43 0.0048
290 GASTROENTERITIS 70 0.0048
291 MASS 67 0.0048
292 JOINT RANGE OF MOTION DECREASED 64 0.0048
293 INTERVERTEBRAL DISC DEGENERATION 44 0.0048
294 THROMBOSIS 381 0.0047
295 UPPER-AIRWAY COUGH SYNDROME 39 0.0047
296 NASAL CONGESTION 277 0.0047
297 PERIPHERAL SWELLING 722 0.0047
298 GASTRIC ULCER 89 0.0047
299 ECCHYMOSIS 32 0.0047
300 DRY THROAT 47 0.0046
301 RESPIRATORY RATE INCREASED 41 0.0046
302 DIABETES MELLITUS 352 0.0046
303 GASTROINTESTINAL INFLAMMATION 36 0.0046
304 RHINITIS 37 0.0046
305 DYSPHONIA 267 0.0046
306 HAEMORRHOIDS 89 0.0046
307 OSTEOARTHRITIS 193 0.0045
308 HAEMATOCHEZIA 251 0.0045
309 LIGAMENT RUPTURE 20 0.0045
310 ODYNOPHAGIA 27 0.0045
311 FEELING JITTERY 86 0.0045
312 ROSACEA 21 0.0045
313 HAEMORRHOIDAL HAEMORRHAGE 22 0.0045
314 PYELONEPHRITIS 39 0.0045
315 HYPOXIA 158 0.0045
316 FOOD POISONING 24 0.0045
317 MULTIPLE ALLERGIES 35 0.0045
318 IRON DEFICIENCY ANAEMIA 41 0.0044
319 URINARY TRACT DISORDER 20 0.0044
320 MUSCULOSKELETAL PAIN 232 0.0044
321 BODY HEIGHT DECREASED 47 0.0044
322 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 310 0.0044
323 ABDOMINAL PAIN UPPER 894 0.0043
324 VITAMIN D DECREASED 37 0.0043
325 MIGRAINE 413 0.0043
326 LOCALISED OEDEMA 20 0.0043
327 THERAPY NON-RESPONDER 194 0.0043
328 THERAPEUTIC RESPONSE SHORTENED 143 0.0043
329 SLEEP APNOEA SYNDROME 82 0.0043
330 EXOSTOSIS 39 0.0043
331 HAND DEFORMITY 56 0.0043
332 PHOTOPHOBIA 80 0.0042
333 SWELLING 398 0.0042
334 LIMB INJURY 115 0.0042
335 COUGH 1182 0.0042
336 SCIATICA 67 0.0042
337 BLOOD LACTIC ACID INCREASED 22 0.0042
338 RENAL DISORDER 194 0.0042
339 GASTROINTESTINAL TOXICITY 20 0.0042
340 LIGAMENT SPRAIN 41 0.0041
341 RHEUMATOID ARTHRITIS 470 0.0041
342 DYSURIA 152 0.0041
343 SLEEP DISORDER 291 0.0041
344 ARTHROPATHY 229 0.0041
345 ANKYLOSING SPONDYLITIS 54 0.0041
346 RED BLOOD CELL COUNT DECREASED 117 0.0041
347 PHARYNGEAL SWELLING 40 0.0041
348 HERNIA 79 0.0041
349 INTENTIONAL PRODUCT USE ISSUE 357 0.0041
350 ALANINE AMINOTRANSFERASE INCREASED 250 0.0041
351 DIARRHOEA HAEMORRHAGIC 38 0.0041
352 NASOPHARYNGITIS 749 0.0041
353 POST PROCEDURAL INFECTION 33 0.0041
354 SPRUE-LIKE ENTEROPATHY 20 0.0041
355 PROCTALGIA 26 0.0040
356 SINUS DISORDER 80 0.0040
357 OSTEOPOROSIS 166 0.0040
358 SENSATION OF FOREIGN BODY 34 0.0040
359 COLITIS MICROSCOPIC 19 0.0040
360 NERVE COMPRESSION 37 0.0040
361 MUSCULOSKELETAL CHEST PAIN 62 0.0040
362 CONCUSSION 31 0.0040
363 APHTHOUS ULCER 31 0.0040
364 WRONG PRODUCT ADMINISTERED 27 0.0040
365 POLYARTHRITIS 21 0.0040
366 HYPONATRAEMIA 224 0.0040
367 IMPAIRED WORK ABILITY 85 0.0040
368 FOOT DEFORMITY 44 0.0040
369 PLEURAL EFFUSION 241 0.0040
370 ANKLE FRACTURE 61 0.0039
371 ACCIDENT 47 0.0039
372 COLITIS ULCERATIVE 175 0.0039
373 THROAT IRRITATION 175 0.0039
374 SMALL INTESTINAL OBSTRUCTION 48 0.0039
375 CHROMATURIA 88 0.0039
376 ENERGY INCREASED 23 0.0039
377 JOINT SWELLING 470 0.0039
378 RIB FRACTURE 80 0.0039
379 BLOOD PRESSURE INCREASED 594 0.0039
380 ORAL CANDIDIASIS 51 0.0039
381 BREAST MASS 26 0.0039
382 DERMATITIS CONTACT 44 0.0039
383 CANDIDA INFECTION 65 0.0038
384 TONSILLITIS 20 0.0038
385 MOBILITY DECREASED 275 0.0038
386 PROTEINURIA 72 0.0038
387 APPETITE DISORDER 25 0.0038
388 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 64 0.0038
389 CHOLECYSTECTOMY 43 0.0038
390 OEDEMA PERIPHERAL 457 0.0037
391 PELVIC PAIN 68 0.0037
392 HYDRONEPHROSIS 28 0.0037
393 CONDITION AGGRAVATED 1132 0.0037
394 HYPERTENSION 788 0.0037
395 ARTERIOSCLEROSIS 35 0.0037
396 GASTROENTERITIS VIRAL 67 0.0037
397 GINGIVITIS 20 0.0037
398 FLATULENCE 210 0.0037
399 MAJOR DEPRESSION 27 0.0037
400 ERYTHEMA OF EYELID 20 0.0037
401 AUTOIMMUNE DISORDER 36 0.0037
402 INTESTINAL OBSTRUCTION 139 0.0037
403 CONSTIPATION 803 0.0037
404 NASAL DRYNESS 23 0.0037
405 HAND FRACTURE 26 0.0037
406 SKIN CANCER 79 0.0037
407 ROTATOR CUFF SYNDROME 47 0.0037
408 LIVER DISORDER 162 0.0036
409 PHOTOPSIA 23 0.0036
410 VIRAL INFECTION 121 0.0036
411 FEBRILE NEUTROPENIA 241 0.0036
412 BLOOD DISORDER 29 0.0036
413 CONJUNCTIVITIS 67 0.0036
414 MUSCULOSKELETAL DISCOMFORT 62 0.0036
415 MIDDLE INSOMNIA 67 0.0036
416 PNEUMONIA 1148 0.0035
417 URINARY INCONTINENCE 105 0.0035
418 HEPATIC STEATOSIS 66 0.0035
419 POLYURIA 29 0.0035
420 ABDOMINAL DISCOMFORT 591 0.0035
421 GENERALISED ERYTHEMA 20 0.0035
422 DRY EYE 175 0.0035
423 POLLAKIURIA 146 0.0035
424 WALKING AID USER 23 0.0035
425 EXTRA DOSE ADMINISTERED 141 0.0035
426 INTERVERTEBRAL DISC PROTRUSION 76 0.0035
427 EATING DISORDER 74 0.0035
428 ARTHRALGIA 1444 0.0035
429 CYST 43 0.0035
430 TOOTH DISORDER 77 0.0035
431 HEART RATE INCREASED 342 0.0034
432 DRUG LEVEL BELOW THERAPEUTIC 19 0.0034
433 WRIST FRACTURE 41 0.0034
434 MOUTH ULCERATION 72 0.0034
435 EAR DISCOMFORT 35 0.0034
436 CONCOMITANT DISEASE AGGRAVATED 21 0.0034
437 THROAT TIGHTNESS 92 0.0034
438 BOWEL MOVEMENT IRREGULARITY 26 0.0034
439 POOR QUALITY SLEEP 73 0.0034
440 ORAL DISCOMFORT 47 0.0034
441 TOOTHACHE 61 0.0034
442 DECREASED IMMUNE RESPONSIVENESS 33 0.0034
443 GASTRIC CANCER 85 0.0034
444 KNEE OPERATION 33 0.0034
445 CARDIOVASCULAR DISORDER 85 0.0033
446 TREATMENT FAILURE 277 0.0033
447 HAEMODIALYSIS 28 0.0033
448 INJECTION SITE EXTRAVASATION 41 0.0033
449 PRODUCT ADMINISTRATION INTERRUPTED 26 0.0033
450 ANAEMIA 630 0.0033
451 SKIN INFECTION 37 0.0033
452 CYSTITIS 105 0.0033
453 SYSTEMIC LUPUS ERYTHEMATOSUS 117 0.0033
454 BLOOD POTASSIUM DECREASED 99 0.0033
455 BACK PAIN 764 0.0033
456 IMMUNOSUPPRESSION 29 0.0033
457 GASTROINTESTINAL PAIN 36 0.0033
458 GINGIVAL PAIN 26 0.0033
459 LOCALISED INFECTION 79 0.0033
460 VASCULITIS 38 0.0033
461 GASTROINTESTINAL DISORDER 291 0.0032
462 SPINAL OPERATION 40 0.0032
463 UVEITIS 44 0.0032
464 BLOOD COUNT ABNORMAL 49 0.0032
465 FEELING HOT 198 0.0032
466 ACUTE RESPIRATORY FAILURE 62 0.0032
467 INFLUENZA 359 0.0032
468 RESPIRATORY TRACT CONGESTION 51 0.0032
469 QUALITY OF LIFE DECREASED 43 0.0032
470 URINE OUTPUT DECREASED 28 0.0032
471 PAIN 1967 0.0032
472 SWOLLEN TONGUE 100 0.0032
473 INCORRECT DRUG ADMINISTRATION DURATION 90 0.0032
474 WEIGHT DECREASED 893 0.0032
475 INJECTION SITE WARMTH 65 0.0032
476 FOLLICULITIS 33 0.0031
477 HEADACHE 1973 0.0031
478 DRUG LEVEL DECREASED 32 0.0031
479 TRANSIENT ISCHAEMIC ATTACK 106 0.0031
480 FATIGUE 2445 0.0031
481 OBESITY 50 0.0031
482 OXYGEN SATURATION DECREASED 176 0.0031
483 SCRATCH 33 0.0031
484 DUODENAL ULCER 22 0.0031
485 DIARRHOEA 2011 0.0031
486 HELICOBACTER INFECTION 32 0.0031
487 FISTULA 35 0.0031
488 CHEST DISCOMFORT 318 0.0031
489 ERUCTATION 60 0.0031
490 OCULAR HYPERAEMIA 147 0.0031
491 INTENTIONAL PRODUCT MISUSE 271 0.0031
492 FAECES DISCOLOURED 67 0.0031
493 URINARY TRACT INFECTION 526 0.0031
494 RESPIRATORY TRACT INFECTION 80 0.0031
495 VERTIGO 186 0.0030
496 FACIAL PARALYSIS 26 0.0030
497 JOINT STIFFNESS 80 0.0030
498 PRESCRIBED OVERDOSE 59 0.0030
499 TOOTH ABSCESS 31 0.0030
500 DEPRESSION 691 0.0030
501 BONE DENSITY DECREASED 95 0.0030
502 UPPER GASTROINTESTINAL HAEMORRHAGE 51 0.0030
503 COLITIS 114 0.0030
504 PAIN IN EXTREMITY 884 0.0030
505 BURNING SENSATION 210 0.0030
506 SENSORY DISTURBANCE 48 0.0030
507 SEPSIS 333 0.0030
508 MULTIPLE FRACTURES 49 0.0030
509 SENSITIVE SKIN 22 0.0030
510 STENT PLACEMENT 24 0.0030
511 LOWER GASTROINTESTINAL HAEMORRHAGE 22 0.0030
512 BLOOD PRESSURE ABNORMAL 59 0.0030
513 ERYTHEMA 610 0.0030
514 SPINAL DISORDER 28 0.0030
515 INJECTION SITE MASS 109 0.0029
516 TREMOR 489 0.0029
517 INSURANCE ISSUE 45 0.0029
518 SKIN LACERATION 32 0.0029
519 CARDIAC FLUTTER 19 0.0029
520 ASTHENIA 1101 0.0029
521 EYE HAEMORRHAGE 39 0.0029
522 DYSPNOEA 1653 0.0029
523 RESTLESS LEGS SYNDROME 53 0.0029
524 GALLBLADDER DISORDER 52 0.0029
525 EYE PAIN 164 0.0029
526 PSYCHOLOGICAL TRAUMA 25 0.0029
527 PAIN IN JAW 82 0.0029
528 ILLNESS 298 0.0029
529 HEAD DISCOMFORT 51 0.0029
530 EOSINOPHIL COUNT INCREASED 24 0.0029
531 EXTRASYSTOLES 20 0.0029
532 HAEMATURIA 98 0.0029
533 BIPOLAR DISORDER 31 0.0028
534 HEPATOMEGALY 28 0.0028
535 PSYCHIATRIC SYMPTOM 21 0.0028
536 CORONARY ARTERY OCCLUSION 39 0.0028
537 GRIP STRENGTH DECREASED 25 0.0028
538 NAUSEA 2247 0.0028
539 WOUND 79 0.0028
540 DUODENAL ULCER PERFORATION 21 0.0028
541 CATARACT 168 0.0028
542 PRODUCT USE ISSUE 530 0.0028
543 MUSCLE SPASMS 516 0.0028
544 PALPITATIONS 329 0.0028
545 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 506 0.0028
546 FACIAL PAIN 25 0.0028
547 HUNGER 39 0.0028
548 HYPERSOMNIA 80 0.0028
549 PULMONARY EMBOLISM 265 0.0028
550 DIABETES MELLITUS INADEQUATE CONTROL 49 0.0028
551 DISCOMFORT 168 0.0028
552 COELIAC DISEASE 27 0.0027
553 LIMB DISCOMFORT 85 0.0027
554 SWELLING FACE 178 0.0027
555 BLOOD PRESSURE DECREASED 181 0.0027
556 LYMPHOMA 42 0.0027
557 CHOKING 53 0.0027
558 CHEST PAIN 503 0.0027
559 WEIGHT INCREASED 606 0.0027
560 OSTEOPENIA 41 0.0027
561 CELLULITIS 136 0.0027
562 NERVE INJURY 30 0.0027
563 BACTERAEMIA 32 0.0027
564 HAIR TEXTURE ABNORMAL 36 0.0027
565 IMMUNODEFICIENCY 40 0.0027
566 INFECTION 388 0.0027
567 HICCUPS 22 0.0027
568 OFF LABEL USE 2345 0.0027
569 RECTAL HAEMORRHAGE 115 0.0027
570 MADAROSIS 31 0.0027
571 HAIR DISORDER 22 0.0027
572 HEAVY MENSTRUAL BLEEDING 24 0.0027
573 MYALGIA 453 0.0027
574 HEPATIC CIRRHOSIS 50 0.0027
575 INFLAMMATORY BOWEL DISEASE 26 0.0027
576 OROPHARYNGEAL DISCOMFORT 24 0.0027
577 HYPERSENSITIVITY 493 0.0027
578 LOWER LIMB FRACTURE 51 0.0027
579 INCONTINENCE 28 0.0026
580 INTENTIONAL DOSE OMISSION 75 0.0026
581 SOMNOLENCE 529 0.0026
582 ANGINA PECTORIS 75 0.0026
583 DYSPHAGIA 248 0.0026
584 HERPES ZOSTER 150 0.0026
585 COVID-19 458 0.0026
586 INCREASED TENDENCY TO BRUISE 24 0.0026
587 SKIN PLAQUE 22 0.0026
588 PRESYNCOPE 63 0.0026
589 ORAL PAIN 58 0.0026
590 INSOMNIA 688 0.0026
591 SURGERY 151 0.0026
592 IMPAIRED QUALITY OF LIFE 37 0.0026
593 ARTHROPOD BITE 19 0.0026
594 THERAPY INTERRUPTED 183 0.0026
595 JOINT DISLOCATION 27 0.0026
596 MOVEMENT DISORDER 82 0.0026
597 MUSCULAR WEAKNESS 290 0.0025
598 MALAISE 1115 0.0025
599 INTERSTITIAL LUNG DISEASE 123 0.0025
600 DYSSTASIA 74 0.0025
601 INITIAL INSOMNIA 26 0.0025
602 BLOOD URINE PRESENT 48 0.0025
603 RESPIRATORY SYNCYTIAL VIRUS INFECTION 22 0.0025
604 VOMITING 1187 0.0025
605 BACK DISORDER 41 0.0025
606 CHILLS 295 0.0025
607 BRAIN NEOPLASM 23 0.0025
608 OVARIAN CYST 25 0.0025
609 DRUG EFFECT LESS THAN EXPECTED 37 0.0025
610 FUNGAL INFECTION 83 0.0025
611 DECREASED APPETITE 577 0.0025
612 RASH MACULO-PAPULAR 55 0.0025
613 BONE DISORDER 45 0.0025
614 HEAD INJURY 78 0.0025
615 LYMPHADENOPATHY 87 0.0025
616 COVID-19 PNEUMONIA 29 0.0025
617 DIZZINESS 1217 0.0024
618 IMMUNE SYSTEM DISORDER 32 0.0024
619 HYPOAESTHESIA 363 0.0024
620 GENERALISED OEDEMA 30 0.0024
621 SARS-COV-2 TEST POSITIVE 32 0.0024
622 NO ADVERSE EVENT 439 0.0024
623 DEVICE DISLOCATION 105 0.0024
624 BODY TEMPERATURE INCREASED 49 0.0024
625 CONTUSION 231 0.0024
626 POST PROCEDURAL COMPLICATION 46 0.0024
627 GROIN PAIN 21 0.0024
628 DEHYDRATION 318 0.0024
629 COLD SWEAT 42 0.0024
630 BRONCHOSPASM 34 0.0024
631 CHOLELITHIASIS 78 0.0024
632 PYREXIA 821 0.0024
633 HOT FLUSH 178 0.0024
634 BALANCE DISORDER 204 0.0024
635 GLOMERULAR FILTRATION RATE DECREASED 29 0.0024
636 UPPER LIMB FRACTURE 47 0.0024
637 RASH MACULAR 82 0.0023
638 HAIR COLOUR CHANGES 29 0.0023
639 HAEMOGLOBIN DECREASED 238 0.0023
640 SPINAL PAIN 27 0.0023
641 HYPOMAGNESAEMIA 32 0.0023
642 URTICARIA 385 0.0023
643 SKIN LESION 63 0.0023
644 PNEUMONIA BACTERIAL 21 0.0023
645 IMPAIRED DRIVING ABILITY 26 0.0023
646 WOUND INFECTION 25 0.0023
647 BEDRIDDEN 30 0.0023
648 LIP SWELLING 76 0.0023
649 GLOSSODYNIA 51 0.0023
650 RESPIRATORY DISORDER 68 0.0023
651 ROAD TRAFFIC ACCIDENT 95 0.0023
652 OEDEMA 123 0.0023
653 TOOTH FRACTURE 25 0.0023
654 ALOPECIA 444 0.0023
655 ANXIETY 642 0.0023
656 PSORIASIS 294 0.0022
657 BREAST PAIN 24 0.0022
658 TOOTH EXTRACTION 28 0.0022
659 HEREDITARY ANGIOEDEMA 24 0.0022
660 INFLUENZA LIKE ILLNESS 184 0.0022
661 DEVICE MALFUNCTION 157 0.0022
662 KNEE ARTHROPLASTY 47 0.0022
663 THERAPEUTIC RESPONSE DECREASED 135 0.0022
664 ADRENAL INSUFFICIENCY 27 0.0022
665 WHITE BLOOD CELL COUNT DECREASED 241 0.0022
666 FALL 739 0.0022
667 TACHYCARDIA 197 0.0022
668 MITRAL VALVE INCOMPETENCE 25 0.0022
669 NERVOUSNESS 115 0.0022
670 HYPOTHYROIDISM 70 0.0022
671 DEATH 1887 0.0022
672 FEELING ABNORMAL 524 0.0022
673 PRODUCT ADMINISTRATION ERROR 44 0.0022
674 ELECTROLYTE IMBALANCE 25 0.0021
675 GAIT DISTURBANCE 411 0.0021
676 PERICARDITIS 36 0.0021
677 NIGHT SWEATS 69 0.0021
678 VITREOUS FLOATERS 21 0.0021
679 ATRIAL FIBRILLATION 208 0.0021
680 PRURITUS GENERALISED 46 0.0021
681 HEPATIC ENZYME INCREASED 145 0.0021
682 HYPERHIDROSIS 272 0.0021
683 SCAB 24 0.0021
684 TRANSFUSION 22 0.0021
685 SKIN DISORDER 70 0.0021
686 EYE INFLAMMATION 20 0.0021
687 HIP ARTHROPLASTY 32 0.0021
688 WHITE BLOOD CELL COUNT INCREASED 80 0.0021
689 DISEASE RECURRENCE 99 0.0021
690 PHARYNGEAL OEDEMA 32 0.0021
691 ALTERED STATE OF CONSCIOUSNESS 45 0.0021
692 PRODUCT USE IN UNAPPROVED INDICATION 514 0.0021
693 CARDIAC DISORDER 194 0.0021
694 BLOOD THYROID STIMULATING HORMONE INCREASED 19 0.0021
695 RETCHING 44 0.0021
696 HYPOKALAEMIA 95 0.0021
697 NEOPLASM MALIGNANT 137 0.0021
698 TINNITUS 93 0.0020
699 PNEUMOTHORAX 32 0.0020
700 STOMATITIS 122 0.0020
701 PARAESTHESIA ORAL 29 0.0020
702 DRUG INEFFECTIVE 2631 0.0020
703 PLATELET COUNT INCREASED 26 0.0020
704 PRURITUS 766 0.0020
705 HYPOAESTHESIA ORAL 30 0.0020
706 BLINDNESS UNILATERAL 28 0.0020
707 PROCEDURAL PAIN 55 0.0020
708 FEELING COLD 55 0.0020
709 MUSCLE TIGHTNESS 32 0.0020
710 HYPOTENSION 396 0.0020
711 PARAESTHESIA 310 0.0020
712 PERIPHERAL COLDNESS 27 0.0020
713 HYPOPHAGIA 50 0.0020
714 HYPOCALCAEMIA 37 0.0020
715 BLOOD GLUCOSE ABNORMAL 36 0.0019
716 DEVICE RELATED INFECTION 30 0.0019
717 URINARY RETENTION 65 0.0019
718 DECREASED ACTIVITY 21 0.0019
719 TENDON RUPTURE 24 0.0019
720 TEMPERATURE INTOLERANCE 20 0.0019
721 RASH GENERALISED 50 0.0019
722 TYPE 2 DIABETES MELLITUS 65 0.0019
723 TASTE DISORDER 39 0.0019
724 IMPAIRED HEALING 63 0.0019
725 VISUAL IMPAIRMENT 237 0.0019
726 EYE IRRITATION 110 0.0019
727 PANCREATITIS 101 0.0019
728 MOOD ALTERED 52 0.0019
729 ADVERSE EVENT 175 0.0019
730 ABDOMINAL PAIN LOWER 48 0.0019
731 POOR QUALITY PRODUCT ADMINISTERED 20 0.0019
732 PULMONARY CONGESTION 25 0.0019
733 BONE PAIN 111 0.0019
734 EMPHYSEMA 19 0.0019
735 STAPHYLOCOCCAL INFECTION 62 0.0019
736 EPISTAXIS 140 0.0019
737 MUCOSAL INFLAMMATION 49 0.0019
738 SPEECH DISORDER 98 0.0019
739 FLUSHING 190 0.0019
740 PRODUCT DOSE OMISSION ISSUE 549 0.0019
741 AMNESIA 121 0.0019
742 EYE INFECTION 21 0.0019
743 THERAPEUTIC RESPONSE UNEXPECTED 83 0.0018
744 SKIN FISSURES 36 0.0018
745 BACK INJURY 20 0.0018
746 INTERNAL HAEMORRHAGE 21 0.0018
747 ORTHOSTATIC HYPOTENSION 32 0.0018
748 LOCAL SWELLING 32 0.0018
749 SNEEZING 41 0.0018
750 NEOPLASM 21 0.0018
751 SKIN HAEMORRHAGE 27 0.0018
752 DISABILITY 36 0.0018
753 SYNCOPE 182 0.0018
754 ABSCESS 29 0.0018
755 MENTAL IMPAIRMENT 44 0.0018
756 SEPTIC SHOCK 78 0.0018
757 SKIN REACTION 25 0.0018
758 RASH 772 0.0018
759 DRUG PRESCRIBING ERROR 34 0.0018
760 NEUROPATHY PERIPHERAL 168 0.0018
761 GLAUCOMA 34 0.0018
762 DISTURBANCE IN ATTENTION 95 0.0018
763 NEEDLE ISSUE 51 0.0018
764 EYE SWELLING 65 0.0017
765 SKIN DISCOLOURATION 80 0.0017
766 MUSCLE ATROPHY 22 0.0017
767 NIGHTMARE 60 0.0017
768 ILL-DEFINED DISORDER 105 0.0017
769 DERMATITIS 36 0.0017
770 BLISTER 96 0.0017
771 LOSS OF CONSCIOUSNESS 218 0.0017
772 SPINAL FRACTURE 34 0.0017
773 DIPLOPIA 44 0.0017
774 PALLOR 46 0.0017
775 PNEUMONITIS 46 0.0017
776 LACRIMATION INCREASED 51 0.0017
777 THYROID DISORDER 26 0.0017
778 PRODUCT PRESCRIBING ERROR 40 0.0017
779 ANAPHYLACTIC REACTION 92 0.0017
780 CARDIAC FAILURE CONGESTIVE 133 0.0017
781 DYSGEUSIA 123 0.0017
782 HYPOKINESIA 24 0.0017
783 METASTASES TO LIVER 29 0.0016
784 HIP FRACTURE 53 0.0016
785 ARRHYTHMIA 78 0.0016
786 MEMORY IMPAIRMENT 226 0.0016
787 LYMPHOCYTE COUNT DECREASED 29 0.0016
788 MYDRIASIS 21 0.0016
789 SCAR 28 0.0016
790 ANGIOEDEMA 72 0.0016
791 HYPERKALAEMIA 57 0.0016
792 PRODUCT DOSE OMISSION IN ERROR 46 0.0016
793 DYSKINESIA 66 0.0016
794 HAEMATOMA 42 0.0016
795 EYE DISORDER 53 0.0016
796 LUNG INFECTION 25 0.0016
797 CENTRAL NERVOUS SYSTEM LESION 22 0.0016
798 PERICARDIAL EFFUSION 37 0.0016
799 CONFUSIONAL STATE 258 0.0016
800 VISION BLURRED 219 0.0016
801 ABNORMAL DREAMS 44 0.0016
802 FLUID RETENTION 81 0.0016
803 INJECTION SITE ERYTHEMA 197 0.0016
804 FULL BLOOD COUNT DECREASED 32 0.0016
805 INJECTION SITE REACTION 109 0.0016
806 PRODUCT DOSE OMISSION 102 0.0016
807 THINKING ABNORMAL 29 0.0016
808 INJECTION SITE BRUISING 124 0.0016
809 GINGIVAL BLEEDING 21 0.0015
810 HOSPITALISATION 236 0.0015
811 DEAFNESS 40 0.0015
812 ACUTE MYOCARDIAL INFARCTION 45 0.0015
813 DRUG DOSE OMISSION 252 0.0015
814 APHASIA 46 0.0015
815 SHOCK 35 0.0015
816 PNEUMONIA ASPIRATION 38 0.0015
817 HYPERTHYROIDISM 22 0.0015
818 ECONOMIC PROBLEM 23 0.0015
819 PHOTOSENSITIVITY REACTION 25 0.0015
820 PANIC ATTACK 55 0.0015
821 PRODUCT SUBSTITUTION ISSUE 86 0.0015
822 PRODUCT AVAILABILITY ISSUE 34 0.0015
823 HYPOACUSIS 64 0.0015
824 LYMPHOPENIA 21 0.0015
825 FRACTURE 28 0.0015
826 MUSCLE TWITCHING 34 0.0015
827 RASH PAPULAR 33 0.0015
828 GASTROINTESTINAL HAEMORRHAGE 122 0.0015
829 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 79 0.0014
830 INJECTION SITE PAIN 441 0.0014
831 GAIT INABILITY 48 0.0014
832 BLOOD SODIUM DECREASED 27 0.0014
833 DRUG EFFECT INCOMPLETE 52 0.0014
834 BLINDNESS 58 0.0014
835 PULMONARY OEDEMA 63 0.0014
836 PRESCRIBED UNDERDOSE 28 0.0014
837 DISORIENTATION 55 0.0014
838 UNEVALUABLE EVENT 105 0.0014
839 PSYCHOMOTOR HYPERACTIVITY 23 0.0014
840 LIVER INJURY 34 0.0014
841 THERAPY CESSATION 71 0.0014
842 INJECTION SITE HAEMORRHAGE 110 0.0014
843 WRONG TECHNIQUE IN DRUG USAGE PROCESS 50 0.0014
844 MYOCARDIAL INFARCTION 240 0.0014
845 HAEMATOCRIT DECREASED 27 0.0014
846 INCREASED APPETITE 26 0.0014
847 HEPATOTOXICITY 30 0.0013
848 THIRST 24 0.0013
849 HAEMATEMESIS 34 0.0013
850 EYE PRURITUS 45 0.0013
851 RASH ERYTHEMATOUS 64 0.0013
852 MULTIPLE SCLEROSIS 64 0.0013
853 ANHEDONIA 35 0.0013
854 DEMENTIA 37 0.0013
855 EXPIRED PRODUCT ADMINISTERED 43 0.0013
856 CARDIOMYOPATHY 19 0.0013
857 BRADYCARDIA 68 0.0013
858 DRUG DEPENDENCE 206 0.0013
859 DRUG EFFECT DECREASED 69 0.0013
860 MANIA 21 0.0013
861 BRAIN FOG 20 0.0013
862 DRUG-INDUCED LIVER INJURY 40 0.0013
863 MENORRHAGIA 25 0.0013
864 PRODUCT USE COMPLAINT 20 0.0013
865 RESPIRATORY DISTRESS 35 0.0013
866 DEPRESSED MOOD 67 0.0013
867 SKIN IRRITATION 58 0.0013
868 INJECTION SITE SWELLING 97 0.0013
869 CRYING 46 0.0013
870 HAEMORRHAGE 132 0.0013
871 AMENORRHOEA 22 0.0013
872 TOOTH LOSS 26 0.0013
873 PULMONARY HYPERTENSION 26 0.0012
874 CYTOKINE RELEASE SYNDROME 25 0.0012
875 CARDIO-RESPIRATORY ARREST 52 0.0012
876 CEREBROVASCULAR ACCIDENT 210 0.0012
877 PRODUCT PHYSICAL ISSUE 25 0.0012
878 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 87 0.0012
879 BLOOD BILIRUBIN INCREASED 33 0.0012
880 METABOLIC ACIDOSIS 39 0.0012
881 LEUKOPENIA 61 0.0012
882 WITHDRAWAL SYNDROME 51 0.0012
883 ABASIA 30 0.0012
884 IRRITABILITY 73 0.0012
885 HEPATITIS 31 0.0012
886 ANAPHYLACTIC SHOCK 31 0.0012
887 DEEP VEIN THROMBOSIS 78 0.0012
888 EMOTIONAL DISORDER 37 0.0012
889 SEROTONIN SYNDROME 23 0.0012
890 SKIN EXFOLIATION 101 0.0012
891 INTENTIONAL DRUG MISUSE 25 0.0012
892 PAIN OF SKIN 32 0.0012
893 LETHARGY 68 0.0012
894 SUICIDAL IDEATION 108 0.0012
895 BLOOD POTASSIUM INCREASED 19 0.0012
896 ADVERSE DRUG REACTION 105 0.0012
897 DRY SKIN 156 0.0012
898 ACNE 88 0.0012
899 INCORRECT DOSE ADMINISTERED 263 0.0012
900 VAGINAL HAEMORRHAGE 50 0.0012
901 SYRINGE ISSUE 20 0.0011
902 ENCEPHALOPATHY 28 0.0011
903 INJURY 80 0.0011
904 COGNITIVE DISORDER 53 0.0011
905 DYSTONIA 22 0.0011
906 DEVICE ISSUE 101 0.0011
907 NERVOUS SYSTEM DISORDER 35 0.0011
908 LUNG NEOPLASM MALIGNANT 46 0.0011
909 DYSARTHRIA 42 0.0011
910 INJECTION SITE RASH 34 0.0011
911 LEUKOCYTOSIS 20 0.0011
912 PRODUCT DISPENSING ERROR 24 0.0011
913 RESPIRATORY FAILURE 80 0.0011
914 INJECTION SITE PRURITUS 73 0.0011
915 AGEUSIA 27 0.0011
916 AGITATION 79 0.0011
917 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
918 ACTIVITIES OF DAILY LIVING IMPAIRED 21 0.0011
919 PLATELET COUNT DECREASED 113 0.0011
920 CARDIAC FAILURE 83 0.0010
921 SEIZURE 118 0.0010
922 INJECTION SITE URTICARIA 25 0.0010
923 RESTLESSNESS 37 0.0010
924 FEAR 27 0.0010
925 OVERDOSE 212 0.0010
926 HALLUCINATION 74 0.0010
927 MENTAL DISORDER 42 0.0010
928 CARDIAC ARREST 78 0.0009
929 BLOOD GLUCOSE DECREASED 45 0.0009
930 PRODUCT QUALITY ISSUE 127 0.0009
931 DELIRIUM 32 0.0009
932 UNDERDOSE 66 0.0009
933 MENTAL STATUS CHANGES 25 0.0009
934 BLOOD GLUCOSE INCREASED 169 0.0009
935 ANGER 30 0.0009
936 APPLICATION SITE PRURITUS 20 0.0009
937 MOOD SWINGS 28 0.0009
938 SEDATION 23 0.0009
939 HYPOGLYCAEMIA 42 0.0009
940 APPLICATION SITE PAIN 19 0.0009
941 MULTIPLE SCLEROSIS RELAPSE 59 0.0009
942 EMOTIONAL DISTRESS 104 0.0009
943 DRUG INTERACTION 136 0.0009
944 EPILEPSY 26 0.0008
945 BLOOD CREATINE PHOSPHOKINASE INCREASED 24 0.0008
946 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 168 0.0008
947 TREATMENT NONCOMPLIANCE 45 0.0008
948 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 21 0.0008
949 GLYCOSYLATED HAEMOGLOBIN INCREASED 20 0.0008
950 PANCYTOPENIA 44 0.0008
951 PRODUCT ADHESION ISSUE 28 0.0008
952 LABORATORY TEST ABNORMAL 23 0.0008
953 FEMUR FRACTURE 24 0.0008
954 ECZEMA 40 0.0008
955 APPLICATION SITE ERYTHEMA 20 0.0008
956 LIVER FUNCTION TEST ABNORMAL 22 0.0008
957 MALIGNANT NEOPLASM PROGRESSION 76 0.0007
958 MEDICATION ERROR 41 0.0007
959 NEUTROPENIA 99 0.0007
960 NEOPLASM PROGRESSION 25 0.0007
961 HYPERGLYCAEMIA 26 0.0007
962 TOXICITY TO VARIOUS AGENTS 118 0.0007
963 OSTEONECROSIS 22 0.0007
964 BREAST CANCER 61 0.0007
965 DEVICE LEAKAGE 28 0.0006
966 VISUAL ACUITY REDUCED 21 0.0006
967 RENAL CANCER 30 0.0006
968 SKIN BURNING SENSATION 45 0.0006
969 DRUG ADMINISTRATION ERROR 19 0.0006
970 DISEASE PROGRESSION 70 0.0006
971 COMPLETED SUICIDE 49 0.0006
972 CEREBRAL HAEMORRHAGE 21 0.0006
973 DRUG WITHDRAWAL SYNDROME 50 0.0006
974 COMA 27 0.0006
975 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 19 0.0006
976 ABNORMAL BEHAVIOUR 22 0.0006
977 ELECTROCARDIOGRAM QT PROLONGED 19 0.0005
978 ACCIDENTAL OVERDOSE 19 0.0005
979 DEVICE BREAKAGE 21 0.0005
980 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 24 0.0005
981 THROMBOCYTOPENIA 57 0.0005
982 INTENTIONAL OVERDOSE 31 0.0005
983 RHABDOMYOLYSIS 20 0.0005
984 SUICIDE ATTEMPT 29 0.0005
985 DERMATITIS ATOPIC 25 0.0005
986 AGGRESSION 23 0.0005
987 ACCIDENTAL EXPOSURE TO PRODUCT 47 0.0005
988 CONVULSION 26 0.0005
989 PRODUCT STORAGE ERROR 34 0.0004
990 MATERNAL EXPOSURE DURING PREGNANCY 34 0.0004